Hunting Hill Global Capital, LLC - COEPTIS THERAPEUTICS HLDGS I ownership

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A116. A total of 18 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hunting Hill Global Capital, LLC ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q2 2024$491
+17.5%
16,3820.0%0.00%
Q1 2024$418
-17.7%
16,3820.0%0.00%
Q4 2023$508
+37.3%
16,3820.0%0.00%
Q3 2023$370
-68.5%
16,3820.0%0.00%
Q2 2023$1,175
-51.3%
16,3820.0%0.00%
-100.0%
Q1 2023$2,411
+47.3%
16,3820.0%0.00%
+100.0%
Q4 2022$1,63716,3820.00%
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q2 2024
NameSharesValueWeighting ↓
Ionic Capital Management LLC 518,728$11,7230.00%
METEORA CAPITAL, LLC 148,443$3,3550.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 100$20.00%
Hunting Hill Global Capital, LLC 16,382$3700.00%
Walleye Capital LLC 109,050$2,4650.00%
AQR Arbitrage LLC 45,745$1,7380.00%
SkyView Investment Advisors, LLC 55,122$10.00%
Skaana Management L.P. 29,180$6590.00%
WOLVERINE ASSET MANAGEMENT LLC 32,489$7340.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders